4MYQ
Selective Inhibition of the Catalytic Domain Of Human Phosphodiesterase 4B With A-33
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-03-21 |
Detector | RIGAKU SATURN 944+ |
Wavelength(s) | 1.5418 |
Spacegroup name | P 42 |
Unit cell lengths | 99.700, 99.700, 47.020 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 49.850 - 1.900 |
R-factor | 0.19 |
Rwork | 0.188 |
R-free | 0.22200 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3g45 |
RMSD bond length | 0.014 |
RMSD bond angle | 1.487 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | REFMAC (5.6.0117) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 49.850 | 1.950 |
High resolution limit [Å] | 1.900 | 1.900 |
Rmerge | 0.087 | 0.483 |
Number of reflections | 35759 | |
<I/σ(I)> | 12.5 | 2.3 |
Completeness [%] | 97.3 | 86.7 |
Redundancy | 3.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 289 | VCID6271 PDE4 AT 7.9 MG/ML IN 20MM HEPES PH 7.5, 100 MM NACL, 1MM DTT, WITH 0.5MM A-33 AGAINST JCSG_ A10 (OPTIMIZATION SCREEN), 328.57MM POTASSIUM FORMATE, 24% W/V PEG 3350, CRYO 20% ETHYLENE GLYCOL AND 0.1MM COMPOUND, CRYSTAL TRACKING ID 232128E12, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K, temperature 289.0K |